- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Amyloid blood biomarker detects Alzheimer's disease ; volume:10 ; number:5 ; year:2018 ; extent:11
EMBO molecular medicine / European Molecular Biology Organization ; 10, Heft 5 (2018) (gesamt 11)
- Creator
-
Nabers, Andreas
Perna, Laura
Lange, Julia
Mons, Ute
Schartner, Jonas
Güldenhaupt, Jörn
Saum, Kai‐Uwe
Janelidze, Shorena
Holleczek, Bernd
Rujescu, Dan
Hansson, Oskar
Gerwert, Klaus
Brenner, Hermann
- DOI
-
10.15252/emmm.201708763
- URN
-
urn:nbn:de:101:1-2022090305364858300646
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nabers, Andreas
- Perna, Laura
- Lange, Julia
- Mons, Ute
- Schartner, Jonas
- Güldenhaupt, Jörn
- Saum, Kai‐Uwe
- Janelidze, Shorena
- Holleczek, Bernd
- Rujescu, Dan
- Hansson, Oskar
- Gerwert, Klaus
- Brenner, Hermann
Other Objects (12)
Simulationsstudien zu zyklisch wiederkehrenden Epidemien bei direkt übertragenen Infektionskrankheiten in räumlich heterogenen grossen Populationen am Beispiel der Masern
Brenner, Hermann
Novel approaches to Alzheimer's disease risk stratification through polygenic risk scores and amyloid beta misfolding in blood plasma
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Comparative and combined analyses of methylation, genetic and environmental risk scores for breast cancer risk prediction
Familial risk and risk-adapted starting age of screening in relatives of patients with prostate cancer
Role of vitamin D and retinol in the long-term prognosis of patients with colorectal cancer
Simulationsstudien zu zyklisch wiederkehrenden Epidemien bei direkt übertragenen Infektionskrankheiten in räumlich heterogenen grossen Populationen am Beispiel der Masern
Brenner, Hermann
Novel approaches to Alzheimer's disease risk stratification through polygenic risk scores and amyloid beta misfolding in blood plasma
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Comparative and combined analyses of methylation, genetic and environmental risk scores for breast cancer risk prediction
Familial risk and risk-adapted starting age of screening in relatives of patients with prostate cancer
Role of vitamin D and retinol in the long-term prognosis of patients with colorectal cancer
Simulationsstudien zu zyklisch wiederkehrenden Epidemien bei direkt übertragenen Infektionskrankheiten in räumlich heterogenen grossen Populationen am Beispiel der Masern
Brenner, Hermann
Novel approaches to Alzheimer's disease risk stratification through polygenic risk scores and amyloid beta misfolding in blood plasma
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Towards a unified protocol for handling of CSF before β-amyloid measurements
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
Comparative and combined analyses of methylation, genetic and environmental risk scores for breast cancer risk prediction
Familial risk and risk-adapted starting age of screening in relatives of patients with prostate cancer